Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial
Authors
Keywords
Coronavirus, MERS, Antiviral, Saudi Arabia, Clinical trial, Lopinavir/ritonavir, Interferon-β1b
Journal
Trials
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-30
DOI
10.1186/s13063-017-2427-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Middle East Respiratory Syndrome
- (2017) Yaseen M. Arabi et al. NEW ENGLAND JOURNAL OF MEDICINE
- PubMed-cited research articles on the Middle East respiratory syndrome
- (2016) Yaseen Arabi et al. Annals of Thoracic Medicine
- A review of treatment modalities for Middle East Respiratory Syndrome
- (2016) Yin Mo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Non-randomised Ebola trials—lessons for optimal outbreak research
- (2016) Giuseppe Ippolito et al. LANCET INFECTIOUS DISEASES
- Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity
- (2016) Chan-Ki Min et al. Scientific Reports
- Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome: a case report
- (2015) Uh Jin Kim et al. ANTIVIRAL THERAPY
- IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study
- (2015) Sarah Shalhoub et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
- (2015) Jasper Fuk-Woo Chan et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials
- (2015) Xiaojie Huang et al. Scientific Reports
- Ribavirin and interferon (IFN)-alpha-2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus (MERS-CoV): a preliminary report of two cases
- (2014) Mohammed Khalid et al. ANTIVIRAL THERAPY
- Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen
- (2014) Nikolaos Spanakis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
- (2014) Jaffar A. Al-Tawfiq et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
- (2014) Ali S Omrani et al. LANCET INFECTIOUS DISEASES
- Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
- (2014) Emmanuel Faure et al. PLoS One
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
- (2013) An-Wen Chan et al. ANNALS OF INTERNAL MEDICINE
- Interferon- and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
- (2013) B. J. Hart et al. JOURNAL OF GENERAL VIROLOGY
- MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment
- (2013) A. H. de Wilde et al. JOURNAL OF GENERAL VIROLOGY
- Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
- (2013) Jasper F.W. Chan et al. JOURNAL OF INFECTION
- Human Cell Tropism and Innate Immune System Interactions of Human Respiratory Coronavirus EMC Compared to Those of Severe Acute Respiratory Syndrome Coronavirus
- (2013) F. Zielecki et al. JOURNAL OF VIROLOGY
- Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
- (2013) Darryl Falzarano et al. NATURE MEDICINE
- Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
- (2013) Darryl Falzarano et al. Scientific Reports
- Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus
- (2012) Peter A Banks et al. GUT
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conducting Research in Disease Outbreaks
- (2009) Ruth Macklin et al. PLoS Neglected Tropical Diseases
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now